The Application dimension of the Obstetric Risk Assessment Solutions market is divided into three primary segments: Prenatal Screening, Labor Management, and Postpartum Monitoring. Prenatal Screening solutions, which incorporate biochemical markers and ultrasonographic parameters, dominate the market because they enable early detection of conditions such as pre‑eclampsia, gestational diabetes, and chromosomal abnormalities, thereby driving substantial capital allocation toward research and deployment. Labor Management tools, including electronic fetal monitoring and uterine activity analytics, capture a sizable share by addressing real‑time decision‑making during delivery, a critical cost‑center for hospitals seeking to reduce adverse events. Postpartum Monitoring platforms, focused on hemorrhage detection, infection surveillance, and maternal vital‑sign trends, contribute a growing portion of revenue as health systems extend risk‑assessment beyond delivery. Together, these application segments shape the overall market size, reflecting the clinical pathway from conception through the postpartum period and informing the broader Obstetric Risk Assessment Solutions segmentation framework.